Embracing the Past, Welcoming the Future: Innovation and humanization in ICU Care - MD Peter Spronk

In this episode of the Fysi Podcast, the host interviews Dr. Peter Spronk, an expert in intensive care and a practicing doctor with over 20 years of experience. Dr. Spronk discusses his interest in the effects of critical illness on patients' quality of life, both during and after their time in the ICU. Dr. Spronk emphasizes the importance of innovation in healthcare, particularly in the ICU environment. He shares examples of innovative approaches, such as using virtual reality (VR) gaming to engage patients during their ICU stay. VR has been shown to reduce pain, alleviate signs of depression, and help patients prepare for surgical procedures. However, Dr. Spronk also highlights the challenges and considerations when implementing new technologies in the ICU. Safety, patient comfort, and individual differences must be carefully considered. He emphasizes the need for larger, adequately powered studies to evaluate the effectiveness of these innovations. The conversation also touches on the humanization of the ICU environment. Dr. Spronk stresses the importance of treating patients as individuals, maintaining open communication, and considering their personal interests and backgrounds to enhance their experience and recovery. Lastly, the discussion covers the role of technology and rehabilitation in ICU care. Dr. Spronk underscores the need for a balanced approach to patient care, including proper nutrition, rehabilitation, and rest, tailored to each patient's needs and condition. Overall, the episode offers valuable insights into the evolving practices and challenges in ICU care, highlighting the potential benefits of innovation while emphasizing the importance of personalized, human-centered care.
1. Van Aerde N, Meersseman P, Debaveye Y, Wilmer A, Gunst J, Casaer MP, Bruyninckx F, Wouters PJ, Gosselink R, Van den Berghe G, Hermans G. Five-year impact of ICU-acquired neuromuscular complications: a prospective, observational study. Intensive Care Med. 2020 Jun;46(6):1184-1193. doi: 10.1007/s00134-020-05927-5. Epub 2020 Jan 22. PMID: 31970446.

2. Nydahl P, Eggmann S, Katsukawa H, Osterbrink J, Parry SM, Schaller SJ, Needham DM. Infection control practices and device management when mobilizing critically ill patients. Eur J Phys Rehabil Med. 2023 Feb;59(1):122-124. doi: 10.23736/S1973-9087.22.07646-8. Epub 2022 Dec 15. PMID: 36519583; PMCID: PMC10035440.

3. Renner C, Jeitziner MM, Albert M, Brinkmann S, Diserens K, Dzialowski I, Heidler MD, Lück M, Nusser-Müller-Busch R, Sandor PS, Schäfer A, Scheffler B, Wallesch C, Zimmermann G, Nydahl P. Guideline on multimodal rehabilitation for patients with post-intensive care syndrome. Crit Care. 2023 Jul 31;27(1):301. doi: 10.1186/s13054-023-04569-5. PMID: 37525219; PMCID: PMC10392009.

4. Hofhuis JG, Spronk PE, van Stel HF, Schrijvers AJ, Rommes JH, Bakker J. Experiences of critically ill patients in the ICU. Intensive Crit Care Nurs. 2008 Oct;24(5):300-13. doi: 10.1016/j.iccn.2008.03.004. Epub 2008 May 9. PMID: 18472265.

5. Hofhuis JGM, Schrijvers AJP, Schermer T, Spronk PE. Health-related quality of life in ICU survivors-10 years later. Sci Rep. 2021 Jul 26;11(1):15189. doi: 10.1038/s41598-021-94637-z. PMID: 34312447; PMCID: PMC8313552.

6. Matejovic M, Huet O, Dams K, Elke G, Vaquerizo Alonso C, Csomos A, Krzych ŁJ, Tetamo R, Puthucheary Z, Rooyackers O, Tjäder I, Kuechenhoff H, Hartl WH, Hiesmayr M. Medical nutrition therapy and clinical outcomes in critically ill adults: a European multinational, prospective observational cohort study (EuroPN). Crit Care. 2022 May 18;26(1):143. doi: 10.1186/s13054-022-03997-z. PMID: 35585554; PMCID: PMC9115983.

7. Vlake JH, van Bommel J, Wils EJ, Korevaar TI, Taccone F, Schut AF, Elderman JH, Labout JA, Raben AM, Dijkstra A, Achterberg S, Jurriens AL, Van Mol MM, Gommers D, Van Genderen ME. Effect of intensive care unit-specific virtual reality (ICU-VR) to improve psychological well-being in ICU survivors: study protocol for an international, multicentre, randomised controlled trial-the HORIZON-IC study. BMJ Open. 2022 Sep 20;12(9):e061876. doi: 10.1136/bmjopen-2022-061876. PMID: 36127077; PMCID: PMC9490570.


Peter Spronk

Fredrik Sjøberg

Hør episoden her: